CXCL1 and non-small cell lung carcinoma: Furthermore, we found that mRNA CXCL1 was increased in TNM stage of III-IV in NSCLC (OR: 1.51, 95%CI:1.19–1.93, P = 0.637, and I2 = 0.0%) (Figure 5E) and ADC (OR: 1.69, 95%CI:1.25–2.28, P = 0.386, and I2 = 6.0%) (Figure 5F), but not in SQC.